Introduction {#s02}
============

Activated macrophages and neutrophils play a key role in the innate immune response to infection by controlling pathogen proliferation and dissemination before antigen-specific adaptive immunity arises. As professional phagocytes, these cells use distinct mechanisms to recognize and engulf the invading agent. The resulting pathogen-containing phagosomal vacuole contains toxicants including reactive species (i.e., free radicals and oxidants), peroxidases, antimicrobial peptides, and hydrolases, which are delivered to the internalized pathogen. The chemical nature of the reactive species in the phagosome depends on the type of phagocytic cell and the presence of host-derived immune mediators at the onset of pathogen internalization. Thus, the term reactive species embodies a collection of free radicals and related oxidants with unique biochemical properties. In this review, we focus on redox processes involved in macrophage-mediated control of invading pathogens, with comparisons to processes in neutrophils where appropriate. We will address phagocyte generation of reactive species, including superoxide radicals (O~2~^•−^/HO~2~^•^), hydrogen peroxide (H~2~O~2~), hydroxyl radicals (^•^OH), nitric oxide (^•^NO), peroxynitrite (ONOO^−^/ONOOH), and hypochlorous acid (HOCl), along with the armamentarium of pathogen-encoded detoxificants that combat host reactive species. Finally, we discuss how the interplay between host-derived reactive species and pathogen antioxidant networks influences the outcome of infection.

Reactive species generated by phagocytes {#s03}
========================================

Superoxide radicals {#s04}
-------------------

Pathogen recognition and engulfment triggers the assembly and activation of macrophage NADPH oxidase, an enzyme complex comprising cytoplasmic regulatory components (p47phox and p67phox) and the membrane-bound gp91*^phox^-*gp22*^phox^* heterodimeric catalytic subunit (cytb~558~, or Nox2). Formation of NADPH oxidase leads to the univalent reduction of O~2~ into O~2~^•−^ radicals that directly damage the internalized pathogen (reviewed in [@bib39]). The reducing equivalents required for this reaction are delivered from NADPH, which is generated in the pentose phosphate pathway, allowing for O~2~^•−^ generation that can last 10--90 min ([@bib89]; [@bib8]; [@bib189]). As electrons flow from NADPH to O~2~, protons move through voltage-gated proton channels, thereby sustaining NADPH oxidase activity ([@bib40]; [@bib39]). The phagocytic process in macrophages takes several minutes ([@bib72]), and macrophages produce 10--20 times less O~2~^•−^ than is produced by neutrophils. O~2~^•−^ (E°′O~2~/O~2~^•−^ = −0.33 V) acts either as a univalent oxidant or a reductant ([@bib159]; [@bib59]). The protonated form of O~2~^•^**^−^**, perhydroxyl radical (HO~2~^•^), is a weak acid (p*Ka* = 4.8) and a more potent oxidant (E°′O~2~^•−^, H^+^/HO~2~^•^ = 1.0 V) compared with O~2~^•−^, and its neutrality facilitates its diffusion across biological membranes. HO~2~^•^ reacts rapidly with poly-unsaturated fatty acids (k ∼10^3^ M^−1^s^−1^), initiating lipid peroxidation reactions ([@bib16]).

O~2~^•−^ can dismutate to H~2~O~2~ and O~2~ in a reaction that consumes hydrogen ions (H^+^). At acidic pH, dismutation is rapid (k = 9.7 × 10^7^ M^−1^s^−1^), but the rate constant of this reaction increases two orders of magnitude (k = 2 × 10^9^ M^−1^s^−1^) in the presence of superoxide dismutases (SODs; [@bib59]; [@bib173]). After pathogen engulfment, the pH of the macrophage phagosome decreases rapidly (10--30 min) to pH ≤5 due to the activity of V-ATPase, and this acidification is essential for pathogen killing. By contrast, the neutrophil phagosome is alkaline (pH ∼7.5--8.5) at early time points after pathogen uptake and drops to pH ∼6--6.5 after ∼1 h ([@bib131]). Thus, the relative O~2~^•−^/HO~2~^•^ concentration ratios and the relevance of their subsequent reactions vary with time as a function of the changing phagosomal pH. For instance, O~2~^•−^ can oxidize iron--sulfur clusters (4Fe-4S; k = 10^6^ to 10^7^ M^−1^s^−1^) at the active site of dehydratases like aconitase ([@bib60]; [@bib196]) and fumarases ([@bib104]; [@bib93]), resulting in release of iron from the clusters and concomitant enzyme inactivation ([@bib58]; [@bib196]). The consequences of the inactivation of these enzymes range from the disruption of the Krebs cycle to alterations of intermediary metabolism. As discussed later, O~2~^•−^ reacts with ^•^NO in a diffusion-controlled manner, yielding peroxynitrite, a strong oxidant with potent antimicrobial activity ([@bib218]; [@bib57]).

Nitric oxide {#s05}
------------

Macrophages synthetize ^•^NO from [L]{.smallcaps}-arginine and O~2~ in the presence of NADPH via a complex oxidoreductase reaction mediated by inducible nitric oxide synthase (iNOS). Immune- and pathogen-derived mediators, including TNF-α, IFN-γ, IL-1β, and bacterial LPS, activate iNOS and other related enzymes and transporters that together ensure potent (micromolar range) and sustained (hours) substrate availability for the production of ^•^NO ([@bib120]; [@bib212]). iNOS has been localized to the cytosol, primary, and tertiary granules, as well as to the vicinity of macrophage and neutrophil phagosomes ([@bib199]; [@bib51]). The majority of the work on iNOS has been done in murine macrophages due to the difficulties in obtaining and appropriately activating human macrophages in vitro ([@bib54]; [@bib116]). Studies using activated human macrophages from patients with infections and/or inflammatory conditions demonstrated substantial person-to-person variability in ^•^NO output ([@bib200]; [@bib21]; [@bib54]). Maximal iNOS protein expression in murine macrophages is achieved 4--5 h after stimulation with IFN-γ and LPS, with ^•^NO fluxes lasting for ∼24 h ([@bib117]; [@bib5], [@bib8]).

^•^NO is a relatively stable free radical and a poor one-electron oxidant (E°′^•^NO,H^+^/HNO = −0.8 V ([@bib14]; [@bib172]). The uncharged nature of ^•^NO allows diffusion to the phagosome, achieving micromolar concentrations. Although a weak oxidant, ^•^NO can react with biologically relevant radicals (e.g., O~2~^•−^; ^•^NO~2~; thiyl, peroxyl, and tyrosyl radicals) with rate constants close to the diffusion-controlled limit (1--3 × 10^9^ M^−1^s^−1^; [@bib135]; [@bib49]; [@bib105]). ^•^NO can also react with and inhibit the heme-cytochrome C-terminal oxidase, initiating site-specific generation of O~2~^•−^ and thus peroxynitrite, at the mitochondrial compartment, thereby impairing energy metabolism by the pathogen ([@bib154]; [@bib22]; [@bib146]; [@bib50]). Importantly, the cytostatic effects of ^•^NO on tumor cells and pathogens largely depend on the inhibition of ribonucleotide reductase (a crucial enzyme for DNA synthesis), achieved via reaction of ^•^NO with the catalytically essential and stable tyrosyl radical ([@bib99]; [@bib117]; [@bib168]).

Peroxynitrite {#s06}
-------------

Peroxynitrite is produced by the diffusion-controlled reaction between O~2~^•−^ and ^•^NO (k = 1 × 10^10^ M^−1^s^−1^; [@bib15]; [@bib82]; [@bib57]), even in the presence of SODs ([@bib152]). Phagocytosis leads to activation of NADPH oxidase, and the resulting O~2~^•−^ production in the presence of ^•^NO leads to peroxynitrite generation in the phagosome. Peroxynitrite is a strong oxidant and can promote one- or two-electron oxidations (E°′ONOO^--^/^•^NO~2~ and ONOO^--^/NO~2~^--^ = 1.4 and 1.2 V). Much of the cytotoxicity of O~2~^•−^ and ^•^NO results from peroxynitrite formation, which impairs mitochondrial respiration and triggers cell death by oxidation- and nitration-mediated reactions (reviewed in [@bib57]). Peroxynitrite anion (ONOO^−^) and its conjugated acid peroxynitrous acid (p*Ka* = 6.8) differ in stability, reactivity, and diffusion capacities; thus the biochemistry of peroxynitrite in biological systems is highly pH dependent ([@bib44]). ONOO^−^ can react with carbon dioxide (CO~2~ ∼1.2 mM, k = 5.8 × 10^4^ M^−1^s^−1^) to yield a nitrosoperoxocarboxylate adduct (ONOOCO~2~^--^) that undergoes fast homolysis, yielding the potent oxidants ^•^NO~2~ and carbonate radical (CO~3~^•−^; [@bib43]; [@bib64]). However, the small diffusion distances (\<1 µm) required for reactive species to reach pathogens inside the phagosomes of macrophages ensure that ONOO^−^ reaches the target before it can be consumed by its fast reaction with CO~2~ ([@bib6]). Nevertheless, the reaction of peroxynitrite with CO~2~ becomes relevant inside the pathogen ([Fig. 1 A](#fig1){ref-type="fig"}). The CO~3~^•−^ generated by this reaction can oxidize amino acid residues such as tyrosine to tyrosyl radical, with the latter rapidly combining with ^•^NO~2~ to generate protein-3-nitrotyrosine ([@bib7]; [@bib57]), one of the molecular footprints of ^•^NO-derived oxidants. This process leads to oxidative posttranslational protein modifications that can participate in the disruption of pathogen structure and metabolism and consequent killing ([@bib57]).

![**Reactive species at the phagosome. (A)** In macrophages (phagosome pH ≤ 5), NADPH oxidase activation (blue sphere) leads to O~2~^•−^ generation toward the phagocytic vacuole (1). O~2~^•−^ dismutates to H~2~O~2~ (2) and/or protonates to generate HO^•^~2~ radical (3). O~2~^•−^ may reach the pathogen by means of anion channels, whereas both H~2~O~2~ and HO~2~^•^ can diffuse across membranes. Immune-stimulated macrophages expressing iNOS (red sphere) produce ^•^NO (4), which diffuses to the phagosome while reacting fast with O~2~^•−^ (5) to yield peroxynitrite anion (ONOO^−^). ONOO^−^ can protonate to peroxynitrous acid (ONOOH); it also permeates the parasite and reacts with CO~2~ (6) to yield ^•^NO~2~ and CO~3~^•−^ radicals (inset). Both ONOO^−^ and ONOOH (7) promote the oxidation and nitration of membrane lipids and proteins (8). **(B)** In neutrophils (phagosome pH ≥ 7.5), MPO-derived HOCl is the dominant oxidant generated in this phagocyte (3) and promotes oxidation and chlorination reactions (9). Although the de novo production of ^•^NO (4) by human neutrophils has rarely been documented, ^•^NO may arise from exogenous sources existing in inflammatory foci and permeate the neutrophil plasma membrane. The other numbers in B denote the same processes described above for A.](JEM_20181886_Fig1){#fig1}

Peroxynitrite can also oxidize thiols (RSH) to their corresponding sulfenic acids (RSOH; [@bib191]; [@bib57]) and can react with transition metals in proteins (e.g., Cu/Zn, Mn, and Fe-SODs), yielding the strongly oxidizing oxo-metal complex and ^•^NO~2~ that can lead to enzyme nitration and inactivation ([@bib56]). Peroxynitrite also reacts fast with Fe-S clusters, leading to Fe release and inactivation of proteins containing these clusters ([@bib91]). In the phagosome, peroxynitrite reacts at the pathogen surface or diffuses into the pathogen cytosol, thereby promoting its toxic effects ([@bib44]). In addition, the secondary radicals arising from the reactions of peroxynitrite with CO~2~ and transition metal centers (^•^NO~2~, CO~3~^•−^, oxo-metal complex and lipid-peroxyl-radicals) can promote protein tyrosine oxidation and nitration ([@bib153]). Peroxynitrite-dependent nitration of pathogen proteins in the phagosomal compartment has been observed in murine macrophages ([@bib103]; [@bib8]). The prolonged respiratory burst observed in immune-stimulated macrophages and the lack of significant myeloperoxidase (MPO) activity in these cells ([@bib69]; [@bib8]) make the formation of peroxynitrite a critical pathway for host-derived pathogen cytotoxicity. The generation of peroxynitrite by human neutrophils and its role in pathogen killing was postulated based on early colocalization studies, which demonstrated the expression of iNOS and MPO in primary granules and the presence of nitrated *Staphylococcus aureus* and *Escherichia coli* in phagosomes ([@bib51]; [@bib203]).

Due to the experimental complications involved in obtaining highly purified neutrophil populations ([@bib27]), together with the difficulties of in vitro immune stimulation of human phagocytes to generate iNOS expression, the extent of peroxynitrite generation in neutrophils remains elusive. It is important to note, however, that one study reported that only ∼20% of cytokine-stimulated neutrophils stained for iNOS, suggesting the existence of heterogeneous subpopulations of cells ([@bib51]).

Hydrogen peroxide and hydroxyl radicals {#s07}
---------------------------------------

H~2~O~2~ is generated either spontaneously or by SOD-dependent dismutation of O~2~^•−^. It is a strong oxidant (E°′H~2~O~2~/H~2~O = 1.77 V), but its reaction with most biomolecules is slow due to a high activation energy. Exceptions are Fe-S clusters present in dehydratases, heme-containing enzymes, and peroxidatic thiols ([@bib208]; [@bib192]). The p*Ka* of H~2~O~2~ is ∼11.6, and thus it will be mostly protonated at physiological pH. Both O~2~^•−^ and H~2~O~2~ can release Fe from Fe-S clusters, and can generate ^•^OH via the Fenton reaction ([@bib197]). ^•^OH is the most reactive of the oxidants (E°′^•^OH/H~2~O = 2.33 V) and reacts with myriad biomolecules. Conflicting evidence on the intra-phagosomal formation of ^•^OH in the absence of exogenously added metals has been reported ([@bib20]; [@bib69]). In view of its high reactivity, ^•^OH generated in the phagosome is unlikely to cause selective damage to internalized pathogens. The site-specific generation of ^•^OH has been proposed as the mechanism underlying DNA damage and toxicity resulting from release of intracellular Fe (which binds to negatively charged DNA; [@bib46]; [@bib71]). A similar site-specific mechanism of ^•^OH generation was proposed for the *Bacillus subtilis* repressor factor PerR that becomes oxidatively inactivated secondary to the in situ metal-catalyzed histidine oxidation ([@bib96]).

Hypochlorous acid: A distinctive neutrophil-derived oxidant {#s08}
-----------------------------------------------------------

HOCl is synthetized by the neutrophil MPO, a cationic heme-containing enzyme stored in the azurophilic granules and released into the phagosome and the extracellular media upon neutrophil activation. MPO reacts with H~2~O~2~ (k = 2 × 10^7^ M^−1^s^−1^) and, in the presence of halide chloride, yields HOCl (p*Ka* = 7.4), a two-electron oxidant (E°′HOCl/Cl^−^ = 1.28 V) that can react with amines to yield the respective chloramines. Chloramines can diffuse into pathogens and react with enzyme thiolates with much higher selectivity than the more reactive HOCl; in this way, chloramines become longer lasting and more efficient HOCl-derived toxicants ([@bib187]; [@bib207]). MPO can also oxidize tyrosine, ascorbic acid, and nitrite, among others, yielding their respective radicals. Amino acid--derived radicals react at diffusion-controlled rates with O~2~^•−^ to form hydroperoxides with potential bactericidal activities ([@bib207]). Preferred targets for HOCl are methionine and cysteine residues (k ∼10^7^ M^−1^s^−1^), as well as tyrosines ([@bib140]; [@bib206]). Tyrosine oxidation yields 3-chlorotyrosine, whereas methionine oxidation yields methionine sulfoxide (Met-SO), which contributes to pathogen killing if not rapidly repaired ([@bib182]; [@bib201]; [@bib165]).

Human and murine macrophages have very little or no MPO activity, and thus HOCl is not produced at significant levels by these cells in vitro ([@bib69]; [@bib8]). By contrast, in vivo, macrophages engulf phagocytosis, thereby acquiring neutrophil MPO and other granule contents at the inflammatory foci ([@bib178]; [@bib177]).

Kinetics and toxicity of phagosomal reactive species in macrophages {#s09}
===================================================================

The relevance of reactive species generated by phagocytes as a mechanism of the innate immune response to invading pathogens is illustrated in individuals with chronic granulomatosis disease, a disease characterized by recurrent bacterial and fungal infections ([@bib54]; [@bib133]). Mouse models of chronic granulomatosis disease have been described that replicate the human disease ([@bib85]; [@bib150]). For example, mice lacking iNOS are more susceptible to various infections including *Mycobacterium tuberculosis* (*Mtb*), *Trypanosoma cruzi*, *Leishmania* spp., *Salmonella typhimurium*, and *Pseudomonas aeruginosa* ([@bib76]; [@bib118]; [@bib214]), although deficiencies in iNOS have not been described in humans. Mice lacking both NADPH oxidase and iNOS are highly susceptible to spontaneous infections arising from native flora and rapidly succumb to infection with virulent or even avirulent *S. typhimurium*, suggesting compensatory activities of NADPH oxidase and iNOS in the control of infection ([@bib176]).

The nature of reactive species generated in the phagosome depends on the immune activation status, tissue localization, and oxygen concentration, and the composition of these reactive species is highly heterogeneous between individual phagosomes ([@bib2]; [Fig. 1](#fig1){ref-type="fig"}). The majority of studies of phagosomal reactive species have been performed at 21% O~2~ (∼200 µM). Tissue O~2~ concentrations range from 15% (∼150 µM) in the alveoli to 4% (∼40 µM) in muscle, and thus phagocytes may respond differently in these different anatomical sites ([@bib30]). For neutrophil NADPH oxidase, the K~M~ (Michaelis constant) for O~2~ is ∼2--3% (20--30 µM); thus at 2--5% O~2~, the enzyme function is at 45--70% of its maximum activity ([@bib130]). iNOS is more sensitive to O~2~ concentration, and thus the K~M~ for O~2~ is higher (∼11% O~2~, 110 µM; [@bib111]). Importantly, the stabilization of hypoxic inducible transcription factor (HIF-1) in response to infection and/or hypoxic conditions leads to an increase in the phagocyte's glycolytic capacity, glucose transport, pentose phosphate pathway activity, and iNOS expression, ensuring optimal O~2~ utilization ([@bib137]).

Peroxynitrite is the most potent oxidant produced by immune-stimulated murine macrophages and is highly cytotoxic to many pathogens, including *E. coli* ([@bib87]), *S. typhimurium* ([@bib41]), *Mtb* ([@bib182]), *P. aeruginosa* ([@bib3]), and *T. cruzi* ([@bib61]; [@bib42]; [@bib8]; [Fig. 1 A](#fig1){ref-type="fig"}). Due to the high reactivity and short biological half-life of peroxynitrite (∼1--20 ms) and the radicals it generates (^•^NO~2~, CO~3~^•−^; in the μs range), unambiguous measurements of intraphagosomal peroxynitrite concentrations have been challenging. Optimal stimulation of murine macrophages leads to the extracellular formation of ∼0.1--0.2 nmol peroxynitrite min^−1^/10^6^ cells, which translates into a phagosomal peroxynitrite production of 0.1--0.4 mM s^−1^, in the small *T. cruzi*--containing vacuole (3--5 fl; [@bib5]). A recent study assessed peroxynitrite generation in response to phagocytosed *T. cruzi*, using a fluorescein-based boronate-derived probe that takes advantage of the fast reaction of peroxynitrite with boronic-esters ([@bib219]; [@bib163]; [@bib151]). The study showed that the amount of peroxynitrite needed to kill *T. cruzi* (LD~100~) was ∼0.6 fmol/parasite; thus the amount of peroxynitrite generated during the time that the pathogen remains in the macrophage phagosome (90 min) is sufficient to kill the parasite. This conclusion was further supported by the complete disruption of parasite ultrastructure, along with the detection of protein tyrosine nitration and oxidation, inside the phagosome of immune-stimulated macrophages ([@bib6], [@bib8]). The LD~100~ for peroxynitrite is much smaller than that reported for H~2~O~2~-dependent *T. cruzi* killing (50--100 fmol/parasite; [@bib119]; [@bib184]), in agreement with the higher microbicidal activity of peroxynitrite.

Several pathogens, such *S. typhimurium* and *Mtb*, are protected against phagosomal O~2~^•−^ and/or limit peroxynitrite generation by encoding periplasmic and/or membrane-bound SOD, demonstrating the importance of reactive species and the synergic activity of NADPH oxidase and iNOS in pathogen killing ([@bib41]; [@bib149]). Following oxidative burst, NADPH oxidase becomes deactivated, whereas ^•^NO generation is maintained for several hours (∼24 h; [@bib5]). In this situation, ^•^NO reactions inside the pathogen become central to host defense. The toxicity of ^•^NO to intracellular pathogens depends on its ability to diffuse and reach parasite targets, leading to energy imbalance, inhibition of DNA synthesis, S-nitrosothiol formation, protein oxidation, and ultimately pathogen death ([@bib65]; [@bib53]; [@bib193]; [@bib182]; [@bib148]).

A pivotal role for the IFN-γ/IL-12/iNOS axis as an immune effector mechanism against *T. cruzi* and *Leishmania* spp. infection was shown using mice lacking IFN-γ receptor and/or iNOS. These mice show enhanced susceptibility to infection and an inability to control parasite proliferation ([@bib75]; [@bib114]). Moreover, H~2~O~2~ production was increased in iNOS-deficient macrophages, which are highly susceptible to *T. cruzi* infection, probably due to the lack of macrophage and/or intra-parasite peroxynitrite generation in the absence of ^•^NO ([@bib75]; [@bib176]). For comparative purposes, the formation of oxidants in the neutrophil phagosome is shown in [Fig. 1 B](#fig1){ref-type="fig"}; the ^•^NO pathway does not seem to be as relevant as in macrophages, and the formation of HOCl becomes a dominant process in neutrophil oxidative responses (reviewed in [@bib83]; [@bib207]; [@bib121]).

Pathogen virulence and antioxidant networks {#s10}
===========================================

Virulence is difficult to define and is one of a number of possible outcomes of host--pathogen interactions ([@bib31]). For the purposes of this review, virulence is defined as the capacity of a pathogen to cause disease, while maintaining survival and rapid proliferation in the mammalian host. Different pathogenic unicellular microorganisms use specific enzymatic and nonenzymatic antioxidant strategies, and each pathogen has its own particular systems; nonetheless, the overall redox processes often share general characteristics, such as the presence of O~2~^•−^, H~2~O~2~, and peroxynitrite, and the necessity for low-molecular-weight (LMW) thiols and thiol-based enzymatic systems, which supply reducing equivalents for peroxide catabolism via connections with intermediary metabolism ([@bib180]). Alternative mechanisms exist, such as the synthesis of melanin by certain fungi and bacteria that scavenges reactive species, inhibits phagocytosis, and increases virulence (reviewed in [@bib132]).

We focus here on *Mtb* and *T. cruzi* as examples of intracellular bacteria and protozoa parasites, respectively, that preferentially invade macrophages. Both rely on a sophisticated network of enzymatic and nonenzymatic antioxidant defenses, allowing the pathogen to persist for years in the infected host. Intracellular redox homeostasis in the pathogen depends on the redox status of the LMW thiols that participate in myriad redox, antioxidant enzyme, and drug detoxification reactions. The reducing equivalents for these redox cascades are delivered from the pentose phosphate pathway and other sources such as NADP-linked dehydrogenases (including mitochondrial and cytosolic malic enzyme, isocitrate dehydrogenase, and transhydrogenases), ensuring reducing power in almost all host microenvironments ([@bib100]; [@bib4]). The pathogen's armamentarium of antioxidant detoxifying defenses includes SODs, peroxidases (i.e., heme dependent, thiol dependent), truncated hemoglobins (^•^NO dioxygenases \[NODs\]), and diverse LMW reductants that work synergistically to combat host-derived oxidants.

Mtb {#s11}
---

*Mtb* is the etiological agent of tuberculosis (TB), which is undergoing a resurgence throughout the world, being responsible for nearly 2 million deaths in 2016. The emergence of multi-drug--resistant isolates further complicates treatment, underscoring the urgency of developing new therapeutic strategies ([@bib33]; [@bib211]). Aerosol transmission is the predominant route of infection of *Mtb*, and inhaled bacilli are engulfed by alveolar macrophages. *Mtb* has developed different survival strategies, which makes it the world's most successful pathogen ([@bib74]; [@bib62]). In an attempt to control bacterial dissemination, infected macrophages release chemokines that recruit other inflammatory cells into the airways, ultimately resulting into the formation of granulomas. Inside the macrophage phagosome, *Mtb* is exposed to different reactive species ([@bib34]; [@bib166]; [@bib194]; [@bib68]), and *Mtb* survival in this hostile environment depends on several bacterial antioxidant systems ([Fig. 2 A](#fig2){ref-type="fig"}).

![**Pathogen antioxidant networks: The examples of *Mtb* and *T. cruzi.* (A)** *Mtb.* NADPH oxidase-derived (O~2~^•−^) and iNOS-derived (^•^NO) radicals can react with specific enzymes (Fe- or Cu-containing SODs to form H~2~O~2~; trHbN to form nitrate) or recombine to form peroxynitrite. H~2~O~2~, peroxynitritous acid (ONOOH), and organic hydroperoxides (ROOH) are reduced particularly by KatG and peroxiredoxins (Prx). Most *Mtb* Prx (AhpC, TPx, PrxQB) can use Trx as reducing substrate. AhpC can also be reduced by AhpD, an adaptor protein that links antioxidant with metabolic enzymes and NADH. NADPH---derived from the pentose phosphate pathway (PPP), isocitrate dehydrogenase (IDH), malic enzyme (ME), and H^+^-transhydrogenases (TH)---is the final electron donor for TrxR and MshR. TrxR reduces Trx B and C (collectively indicated herein as Trx's). The one-Cys Prx AhpE is reduced by Mrx-1 either directly (data not shown) or through the formation of a mixed disulfide with MSH, which is reduced by Mrx-1 in a monothiolic mechanism that leads to mycothiolated Mrx-1 (Mrx-1-SM) and is resolved by MSH/MshR/NADPH. MsrA and B reduce S-- and R--Met-SO, respectively, and accept electrons from the Trx/TrxR/NADPH system. **(B)** *T. cruzi.* Enzymatic and nonenzymatic redox-active molecules use reducing equivalents from NADPH---derived from the PPP, IDH, ME, and TH---are funneled through the T(SH)~2~, GSH, ascorbate (ASC), and/or TXN-I/II redox systems. H~2~O~2~ is metabolized by APxCcP at the endoplasmic reticulum, mitochondria, and plasma membrane using ASC/Cyt c^II^ as the electron donors. Dehidroascorbate (DHA) is reduced by a direct reaction with T(SH)~2~. Organic hydroperoxides (ROOH) are substrates for GPX-II that uses GSH. T(SH)~2~ reduces oxidized GSH (GSSG), while TR reduces TS~2~. Mitochondrial O~2~^•−^ formation by the electron transport chain (mainly at complex III) is detoxified by Fe-SODA with H~2~O~2~ generation. ^•^NO can reach the mitochondria and inhibit respiration at complex IV (CIV; with an enhanced O~2~^•−^ generation). Fe-SODA outcompetes for O~2~^•−^ inhibiting ONOO^−^ formation. Mitochondrial peroxiredoxin (MPX) decomposes H~2~O~2~ and/or ONOO^−^, probably using reduced TXN-II and T(SH)~2~ as the reducing substrate (dashed arrows). Met-SO is repaired by the action of MsrB at the expense of TXN. In the cytosol, cytosolic peroxiredoxin (CPX) detoxifies ROOH. T(SH)~2~ is synthesized from two molecules of GSH and one spermidine in a reaction catalyzed by the enzyme trypanothione synthetase (TS). Met-SO is repaired by the presence of MsrA and B in the different compartments.](JEM_20181886_Fig2){#fig2}

### The mycothiol (MSH)-dependent antioxidant network of *Mtb* {#s12}

In most eukaryotes and bacteria, glutathione (GSH) is the main LMW thiol responsible for maintaining redox homeostasis in the cell. *Mtb* lacks GSH and instead relies on MSH (1-D-*myo-*inosityl-2-N-acetylcysteinyl-amido-2-deoxy-α-D-glucopyranoside) as its main LMW thiol ([@bib124]). MSH biosynthesis is complex and proceeds through a five-step pathway with L-inositol-1-phosphate and UDP-N-acetylglucosamine as the initial substrates ([@bib126]). *Mtb* strains with decreased MSH content are hyper-susceptible to oxidants, acidic conditions, and drugs ([@bib25], [@bib26]; [@bib129]). *Mtb* can also synthetize ergothioneine (2-mercaptohistidine trimethylbetaine; [@bib63]) and gamma-glutamyl cysteine ([@bib171]), and the interplay between these three thiols ensures optimal protection of the bacteria against reactive species ([@bib183]).

The flavoenzyme mycothiol disulfide reductase (MshR) is responsible for maintaining MSH in its reduced state and is essential for *Mtb* survival ([@bib77]). Upon oxidant exposure, several proteins form mixed disulfides with MSH, and these disulfides are then reduced by the glutaredoxin-like protein mycoredoxin-1 (Mrx-1; [@bib195]; [@bib80]). Mrx-1 is in turn reduced by MSH/MshR using the reducing equivalents provided by NADPH ([@bib195]). A novel MSH-dependent reductase (Rv2466c) involved in the activation of the pro-drug TP052, a thieno-pyrimidine derivative able to kill *Mtb*, was found to be essential for bacterial survival during exposure to H~2~O~2~ ([@bib127]; [@bib1]; [@bib164]). Recently, it was shown that Rv2466c functions as a noncanonical nitroreductase that relies on MSH for the reduction of nitro-containing compounds ([@bib123]). Under oxidative stress conditions, *Mtb* increases (via sigma H, E, and B) the expression of thioredoxin reductase/thioredoxin together with enzymes involved in MSH synthesis ([@bib156]; [@bib125]). Moreover, ergothioneine biosynthesis increases under acidic conditions (such as those found in macrophage phagosome). WhiB3, a 4Fe-4S containing protein, regulates *Mtb* gene expression, sensing changes in the MSH redox status ([@bib112]; [@bib167]). Interestingly, *Mtb* strains lacking whiB3 or sigma H have attenuated virulence in animal models ([@bib90]; [@bib112]), underscoring the importance of the regulatory systems involved in redox homeostasis for bacterial pathogenesis.

Sulfur metabolic pathways (required for the synthesis of cysteine, MSH, and ergothioneine) have also been shown to be essential for *Mtb* virulence and survival and are up-regulated under oxidative stress conditions ([@bib138]). Inhibitors that target these redox biosynthetic pathways are currently under investigation ([@bib138]). Recently, the novo [L]{.smallcaps}-arginine biosynthetic pathway was shown to be essential for *Mtb* growth and virulence, as one of the early adaptive responses to oxidative stress ([@bib188]). Disruption of the pathway leads to LMW thiol depletion, increase in oxidative stress, and DNA damage with rapid sterilization of *Mtb* ([@bib188]).

### Other *Mtb* antioxidant enzymes {#s13}

One of the major secretory proteins found in clinical human isolates from patients with TB is Fe-SOD, suggesting that this protein has a major role in *Mtb* pathogenesis ([@bib45]). Two types of SODs are found in *Mtb*, SODA and SODC. SODA is Fe dependent and is abundantly released from virulent *Mtb* strains ([@bib19]). SODC is Cu dependent and is associated with the outer bacterial membrane. Both SODs protect *Mtb* from the action of macrophage-derived O~2~^•−^ ([@bib149]; [@bib37]). Fe-SODA was reported to be essential for *Mtb* growth, and bacteria with reduced Fe-SODA content are largely attenuated ([@bib48]). Both Fe-SODA and Cu-SODC can inhibit immune functions as well as promote macrophage apoptosis, contributing to bacterial survival by mechanisms independent of O~2~^•−^ dismutation ([@bib101]).

The genome of *Mtb* encodes several heme- and nonheme-dependent peroxidases ([@bib35]). Catalase-peroxidase (KatG) is a heme-containing peroxidase that acts either as a catalase or peroxidase, using a broad range of oxidizing and reducing substrates ([@bib88]; [@bib202]). KatG is required for the activation of the first-line anti-*Mtb* pro-drug isoniazid, and inactivating mutations cause isoniazid resistance ([@bib216]; [@bib198]). Isoniazid activation involves its one-electron oxidation by KatG compound I, generating an isoniazid-NAD adduct that inhibits enoyl-acyl carrier protein reductase, thereby impairing mycolic acid biosynthesis and damaging the structure of the bacterial wall ([@bib198]). *Mtb* strains lacking KatG are attenuated in wild-type and iNOS^−/−^ mice, but they replicate and persist in mice lacking gp91*phox*, indicating that a major contribution of KatG to pathogenesis is via reduction of NADPH oxidase--derived hydroperoxides ([@bib128]).

*Mtb* alkyl-hydroperoxide reductase-C (AhpC) is a typical two-cysteine peroxiredoxin that catalyzes the reduction of H~2~O~2~, organic hydroperoxides (ROOH), and peroxynitrite ([@bib23]; [@bib73]). AhpC is reduced by TrxC (and TrxR) using NADPH ([@bib86]; [@bib210]); it can also be reduced by NADH and by the Trx-like protein AhpD ([@bib24]; [@bib106]). Clinical isolates of isoniazid-resistant *Mtb* strains frequently compensate for the loss of KatG by increasing the expression of AhpC ([@bib174]; [@bib38]). *Mtb* strains harboring inactive mutants of components of the AhpC complex are susceptible to killing by murine macrophages expressing acidified nitrite and iNOS ([@bib175]; [@bib106]), underscoring the importance of this enzyme for detoxification of reactive nitrogen species by *Mtb*. Moreover, the persistence of *Mycobacterium bovis* bacillus Calmette-Guerin in infected macrophages decreases when bacterial AhpD is inactivated ([@bib55]). *Mtb* strains lacking AhpC show increased susceptibility to ROOH ([@bib179]) and peroxynitrite, and decreased survival in macrophages ([@bib109]).

*Mtb* expresses a thiol peroxidase (TPx), which is more efficient than AhpC in peroxynitrite reduction and also reduces H~2~O~2~ and ROOH using TrxB/C as reducing substrates ([@bib86]). *Mtb* lacking TPx is hypersensitive to H~2~O~2~ and ^•^NO; these mutants fail to grow and survive in murine macrophages and show attenuated virulence in mouse models of TB ([@bib78]). *Mtb* also encodes an alkyl hydroperoxide reductase-E (AhpE), a different one-cysteine peroxiredoxin belonging to a subfamily unique to bacteria. AhpE is very efficient in reducing peroxynitrite and fatty acid hydroperoxides ([@bib79]; [@bib160]), itself being reduced either by Mrx-1 directly or after formation of a mixed disulfide with MSH ([@bib80]). The residues involved in the interactions of AhpE with Mrx-1 have been recently described, serving as a starting point for structure-guide drug design ([@bib95]).

The other two peroxiredoxins expressed in *Mtb* are members of the PrxQ subfamily. PrxQB is essential for *Mtb* growth in cholesterol-rich media ([@bib66]; [@bib98]; [@bib209]) and catalyzes the reduction of peroxynitrite, fatty acid hydroperoxides, and H~2~O~2~ at the expense of TrxB/C ([@bib161]). Finally, *Mtb* protection against host-derived ^•^NO relies on the presence of the truncated hemoglobin N (trHbN) that associates with the bacterial membrane via a preA helix that is found only in pathogenic bacteria ([@bib162]). trHbN protects aerobic respiration from ^•^NO inhibition and prevents its own irreversible oxidation and nitration by rapidly metabolizing ^•^NO to an innocuous nitrate via the NOD reaction. trHbN catalyzes the NOD reaction with a second-order rate constant, k~NOD~ = 7.45 × 10^8^ M^−1^s^−1^, corresponding to a rate approaching the diffusion limit, making it the most efficient NOD described thus far ([@bib36]). *Mtb* trHbN is highly expressed during macrophage infection and maintains its NOD activity even under low oxygen concentrations ([@bib141]). A recent study elucidated the mechanism underlying the highly efficient ^•^NO-scavenging ability of *Mtb* trHbN ([@bib29]).

T. cruzi {#s14}
--------

*T. cruzi* belongs to the kinetoplastid family (which includes *Leishmania* spp. and other *Trypanosoma* spp.), a primitive eukaryote parasite responsible for American trypanosomiasis or Chagas disease, which infects an estimated 7 million people worldwide, with another 28 million people at risk of infection. The disease is transmitted via insect vectors and is spreading as a result of both human and vector migration ([@bib143]). While the acute phase of Chagas disease is usually asymptomatic, *T. cruzi* establishes chronic infection, characterized by organ damage that mainly, but not exclusive, affects the heart (myocarditis) and the intestine (megacolon). The pathogenesis of chronic Chagas disease myocarditis is complex and involves parasite immune evasion strategies, genetically determined defects in host immune homeostasis, and auto-reactive phenomena characterized by the presence of autoantibodies. *T. cruzi* genetic material can be found in damaged tissue during chronic infection, indicating an active role of parasite persistence in pathology ([@bib157]; [@bib12]). Indeed, despite the generation of a robust immune response, the host fails to eliminate parasites from tissues, enabling the pathogen to persist chronically for years.

### The trypanothione-dependent antioxidant network of *T. cruzi* {#s15}

*T. cruzi* relies on an unusual redox metabolism, as its major LMW thiol is a derivative of GSH and spermidine: N^1^, N^8^-bis(glutathionyl)-spermidine or trypanothione (T(SH)~2~/TS~2~; reduced and oxidized trypanothione, respectively; [@bib52]). This thiol is synthetized by the action of monoglutathionyl spermidine synthetase and trypanothione synthetase (TS; [Fig. 2 B](#fig2){ref-type="fig"}). In *T. cruzi*, both conjugation reactions are performed by TS ([@bib134]). Although *E. coli* is able to synthesize monoglutathionyl spermidine ([@bib17]), a complete biosynthetic pathway for T(SH)~2~ is exclusive to kinetoplastids.

T(SH)~2~ is more reactive than GSH at physiological pH due to its lower p*Ka* (∼7.4 and 8.3, respectively). TS~2~ is reduced by the flavoenzyme trypanothione reductase (TR), with reducing equivalents provided by NADPH. In all cases T(SH)~2~ delivers reducing equivalents to intermediary molecules, such as GSSG, dehydroascorbate), or the dithiol protein tryparedoxin (TXN); in their reduced state, these molecules can transfer electrons to the parasite peroxidases, reductases, glyoxalases, and transferases ([@bib107]). TXN represents a distinct molecular class within the thioredoxin superfamily of oxidoreductases, differing from host cells, in which similar redox reactions are mediated by thioredoxins. *T. cruzi* contains two TXNs; one is a cytosolic protein (TXN-I) and the other a transmembrane protein (TXN-II) that is anchored to the surface of endoplasmic reticulum and mitochondria with the redox domain oriented toward the cytoplasm ([@bib10]). An ATP-dependent transporter for both TS~2~ and T(SH)~2~ has been described in *Leishmania major* and may also exist in *T. cruzi* ([@bib142]). Trypanothione and TXN metabolism in kinetoplastids are considered attractive target pathways for drug development, but efforts to inhibit TR activity have met with little success. In *Trypanosoma brucei*, TR activity needs to be reduced \>90% to render parasites avirulent ([@bib94]).

### *T. cruzi* antioxidant enzymes {#s16}

Kinetoplastids express only Fe-SODs for O~2~^•−^ detoxification. In *T. cruzi*, four Fe-SODs have been described and are located in distinct subcellular compartments. Fe-SODA and SODC reside in the mitochondrial matrix, Fe-SODB1 in the cytosol, and Fe-SODB2 in the glycosome, a uniqueparasite cellular organelle in which several glycolytic enzymes are located ([@bib186]; [@bib84]). While some authors have reported the presence of an extracellular Fe-SOD due to the presence of *T. cruzi* SOD-specific antibodies in patients with Chagas disease, the exact nature and mechanism of release of this Fe-SOD remain elusive ([@bib110]).

Despite the high structural homology among *T. cruzi* Fe-SODs, they have disparate susceptibilities to peroxynitrite inactivation. Cytosolic Fe-SODB is extremely resistant to oxidant inactivation as compared with its mitochondrial counterpart ([@bib108]). *T. cruzi* Fe-SODs readily eliminate O~2~^•−^ and may contribute to *T. cruzi* intracellular survival in the vertebrate host by various immune evasion mechanisms. These mechanisms include protection from the directly cytotoxic effects of O~2~^•−^/HO~2~^•^ on parasite mitochondria in the macrophage phagosome, inhibition of ONOO^−^ formation in ^•^NO-challenged parasites, and modulation of redox-signaling processes that trigger parasite programmed cell death ([@bib144], [@bib148]; [@bib50]). Indeed, peroxynitrite generation was demonstrated in the presence of ^•^NO and, importantly, parasites with increased mitochondrial Fe-SODA content detoxified O~2~^•−^ before peroxynitrite formation ([@bib146]; [@bib50]). These observations are of central importance during the chronic stage of Chagas disease, in which ^•^NO is produced by different cellular sources, leading to control of pathogen proliferation by the host. Efforts are being made to unravel the structural characteristics of Fe-SOD in an effort to design specific inhibitors ([@bib11]).

*T. cruzi* peroxiredoxins participate in parasite virulence by means of efficient H~2~O~2~ and peroxynitrite detoxification in the phagosome ([@bib8]). In *T. cruzi*, increased expression of both mitochondrial and cytosolic peroxiredoxins is associated with enhanced virulence in mouse models of Chagas disease, resulting in high parasitemia and severe tissue damage ([@bib147]; [@bib215]). Recently, holdase activity has been demonstrated for *Leishmania* peroxiredoxins and shown to be involved in parasite virulence ([@bib32]). Whether this pathway is also active in *T. cruzi* infection is still under investigation.

To date, only one heme-containing peroxidase was described in *T. cruzi, Tc*APxCcP, a hybrid type-A peroxidase that uses both ascorbate and cytochrome c as reducing substrates for H~2~O~2~ detoxification ([@bib205]). *Tc*APxCcP is a membrane-bound peroxidase located at the endoplasmic reticulum and mitochondria in all parasite stages and at the plasma membrane in the infective stages of the *T. cruzi* life cycle ([@bib81]). Parasites overexpressing *Tc*APxCcP are more resistant to H~2~O~2~ toxicity, even more so than those overexpressing cytosolic and/or mitochondrial peroxiredoxin ([@bib145]). Although the enzyme is not essential for the establishment of infection ([@bib185]), parasites with higher *Tc*APxCcP content show increased virulence in the vertebrate host, underscoring its role in pathogenicity ([@bib81]).

Finally, *T. cruzi* contains two GSH-dependent--like peroxidases (GPXs) that lack selenium at the active site. All trypanosomatid GPXs have a phospholipid hydroperoxidase-type structure and can metabolize fatty acids and phospholipid hydroperoxides, but none have activity with H~2~O~2~ ([@bib204]). GPX-I is located at the cytosol and glycosome whereas GPX-II localizes to the endoplasmic reticulum in the noninfective epimastigote. GPX-I has a higher affinity for TXN-I, with rates of hydroperoxide reduction 8--15-fold higher than with GSH ([@bib204]). Overexpression of GPX-I and -II confers resistance to exogenous H~2~O~2~, although this oxidant cannot be directly metabolized by either peroxidase, suggesting that increased concentrations of these enzymes confers protection by detoxifying secondary products of lipid peroxidation ([@bib204]). The relevance of the *T. cruzi* GPXs in the infective stage of the parasite is still to be determined. Overall, *T. cruzi*'s armamentarium of antioxidants acts as a virulent factor by detoxifying reactive species at the phagosomal compartment ([Fig. 2 B](#fig2){ref-type="fig"}). However, potentially conflicting observations were reported using gp91-*phox*^−/−^ macrophages, which failed to allow proliferation of some *T. cruzi* strains ([@bib136]; [@bib169]). This observation might be explained by the requirement for a mild oxidizing environment for efficient iron mobilization, which enhances intracellular parasite growth ([@bib9]). However, in spite of this observation, pioneering experiments using murine macrophages defective in NADPH oxidase activity ([@bib184]) or from silica-treated mice (in which phagocyte respiratory burst is exhausted; [@bib92]; [@bib190]) showed that these cells are highly susceptible to *T. cruzi* infection. Future studies should clearly define the role of redox signaling in parasite iron metabolism and proliferation and the "switch" to conditions leading to oxidative killing.

Pathogen repair systems for oxidized biomolecules {#s17}
=================================================

Another virulence strategy relies on pathogen-encoded repair systems that limit potentially harmful oxidation of proteins and DNA. Methionine oxidation is mediated by different reactive species including H~2~O~2~, peroxynitrite, HOCl, and metal catalyzed oxidation systems, giving rise to the epimers methionine-(*S*) and methionine-(*R*)-sulfoxide (Met-SO; [@bib201]). Enzymatic mechanisms for methionine oxidation have also been described ([@bib102]; [@bib28]; [@bib213]). Methionine sulfoxide reductases (Msr) had been described in a wide range of pathogenic species, and these enzymes reduce Met-SO using the reducing equivalents form the Trx/TrxR and NADPH ([@bib18]). Two different enzymes, MsrA and MsrB, catalyze the reduction of the diastereoisomers of oxidized methionine. The activity of MsrA is restricted to Met(*S*)-SO residues in proteins, whereas MsrB reduces Met(*R*)-SO. Some pathogenic bacteria contain a fusion protein of MsrA and B (MsrAB), which has higher catalytic efficiency than the individual enzymes ([@bib70]). Organisms lacking Msr's are more susceptible to oxidative stress, have a shortened life span and, for bacterial pathogens, have reduced virulence ([@bib115]; [@bib182]; [@bib217]). *Mtb* expresses both MsrA and B, but their contribution to oxidative stress is limited. *Mtb* lacking MsrA or MsrB alone does not show increased susceptibility to HOCl or acidified nitrite, whereas strains lacking both enzymes do ([@bib97]). *Mtb* MsrA also reduces the methylsulfinylfuranosyl groups in lipoarabinomannan, a glycoprotein formed from the interaction of two-electron oxidants with components of the bacterial cell wall ([@bib181]).

Trypanosomes contains both MsrA and MsrB; MsrA is located at the cytosol and MsrB at the parasite mitochondria. The activity of both enzymes depends on reducing equivalents delivered from the T(SH)~2~-TXN-NADPH system. In *T. brucei*, only MsrA seems to participate in H~2~O~2~ resistance, as no change to oxidant sensitivity was observed when expression of MsrB was reduced ([@bib67]). The contribution of Msr in *T. cruzi* virulence is still not well established and requires further study.

Another important system for *T. cruzi* virulence involves the sanitization of oxidized bases in DNA. Guanine is highly susceptible to oxidation, and its most common oxidation product is 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxoG), which is potentially mutagenic due to its structural similarity with thymine ([@bib122]). All organisms contain 8-oxoG repair systems, which catalyze the removal of 8-oxoG from the cellular pool (MuT and MTH1 in bacteria and eukaryotes, respectively) and/or eliminate 8-oxoG from DNA (MutM/MutY and OGG1/MUTYH for bacteria and eukaryotes, respectively; [@bib113]; [@bib13]). The *Mtb* genome contains a high guanine and cytosine (GC) content, suggesting high susceptibility to oxidative stress, but it also encodes highly efficient DNA repair systems, which could constitute candidates for drug targeting ([@bib47]; [@bib158]). Trypanosomes also contain efficient DNA repair systems ([@bib139]), and overexpression of some components of these systems leads to benznidazol resistance, indicating that one of the principal targets of benznidazol is the nucleotide pool ([@bib155]). The extensive incorporation of oxidized nucleotides as a result of benznidazol treatment normally leads to potentially lethal double-stranded DNA breaks in the pathogen genome.

Conclusions and perspectives {#s18}
============================

While the past few decades have seen considerable progress in our understanding of the biology of reactive species in the phagosomal compartment, a precise understanding of the interplay, effects, and metabolism of these species remains challenging. On one hand, pathogens have a large variety of antioxidant components, levels, and responses that serve to safeguard microbial viability and proliferation. On the other hand, phagocytic cells have multifaceted oxidative mechanisms which, acting independently or synergistically in a stimuli-dependent and time-dependent manner, assist in the control of pathogen dissemination.

An intriguing question, for which there are virtually no data available for macrophages, is how microbial substrates, proteins, or enzymes may be secreted or extruded to potentially modulate the oxidant tone in the phagosome. In the case of trypanosomes, active transport of reduced/oxidized thiols has been recently reported and may serve to pump thiols to the phagosome ([@bib142]). Similarly, ergothioneine is secreted by *Mtb* ([@bib170]). Both observations contribute to the speculation that high reductant concentrations may be achieved in the phagosomal lumen, thereby attenuating the oxidative assault and constituting a first antioxidant "shield."

The antioxidant responses of pathogenic microorganisms secondary to the release of reactive species at the phagosome remain an unknown and fascinating field. Pathogens may also regulate the extent of oxidant production by modulating the host immune response (i.e., delay in the maturation of the phagocytic vacuole, inhibition of NADPH oxidase assembly, and inhibition of granule fusion, among others). Several other factors influence the magnitude of the oxidative assault, including tissue O~2~ concentration and pro-inflammatory mediators (e.g., cytokines) that prime macrophages for an increase in oxidant capabilities. In addition, low levels of host-derived redox mediators such as H~2~O~2~ and peroxynitrite can trigger up-regulation of pathogen antioxidant defenses. Importantly, the ability of virulent versus avirulent strains of microbes to cope with reactive species greatly differs. The importance of phagocyte-mediated oxidative killing of pathogens is well documented in humans, considering the poor outcome of infection in individuals with deficiencies in different components of the host oxidant response. Conversely, pathogens with robust antioxidant systems result in more virulent phenotypes. Distinctive characteristics of the pathogen antioxidant networks in relation to their mammalian host cell counterparts offer potential for the development of pharmacological therapies to interfere with the redox-based detoxification systems of infective organisms.
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